# GSX2

## Overview
GSX2, or GS homeobox 2, is a gene that encodes a homeodomain transcription factor involved in the development of the central nervous system. The protein product, GS homeobox 2, plays a pivotal role in neurogenesis, particularly within the lateral ganglionic eminence (LGE) of the brain, where it influences the differentiation and proliferation of neural progenitor cells. As a transcription factor, GS homeobox 2 is integral in specifying neuronal fates, maintaining progenitor cell identity, and balancing proliferation and differentiation during brain development. Its interactions with other proteins and DNA are crucial for modulating gene expression, which is essential for the proper formation of neuronal subtypes. Mutations in the GSX2 gene have been linked to significant neurodevelopmental disorders, highlighting its importance in brain development and function (Waclaw2009Distinct; De2019Agenesis; Pei2011Homeobox).

## Function
GSX2 (GS homeobox 2) is a transcription factor that plays a critical role in the development of the central nervous system, particularly in the lateral ganglionic eminence (LGE) of the brain. It is involved in the specification of neuronal fates during neurogenesis, influencing the differentiation and proliferation of neural progenitor cells. GSX2 is expressed in a temporally dynamic manner, initially promoting the specification of striatal projection neurons and later being crucial for the development of olfactory bulb interneurons (Waclaw2009Distinct).

GSX2 functions by repressing dorsal telencephalic identity in LGE progenitors, maintaining the identity of the dorsal LGE (dLGE) and ventral LGE (vLGE) until late embryonic stages. This repression is essential for the proper development of striatal projection neurons and olfactory bulb interneurons (Waclaw2009Distinct). GSX2 also plays a role in maintaining progenitors in an undifferentiated state, thus expanding the progenitor pool and balancing proliferation and differentiation in telencephalic progenitors (Pei2011Homeobox).

The gene's activity is crucial for the correct patterning of the LGE, with its absence leading to a reduction in specific neuronal subtypes and a shift in cell fate from interneurons to projection neurons (Waclaw2009Distinct).

## Clinical Significance
Mutations in the GSX2 gene are associated with significant developmental brain defects, particularly affecting the basal ganglia. Recessive mutations in GSX2 can lead to agenesis of the putamen and globus pallidus, as well as dysgenesis of the caudate nuclei and olfactory bulbs. These mutations result in severe neurodevelopmental disorders, including spastic tetraparesis, generalized dystonia, and intellectual impairment (De2019Agenesis). The nonsense variant p.(S9*) and the missense variant p.(Q251R) in GSX2 have been identified in patients with these conditions, leading to impaired protein expression and function (De2019Agenesis).

GSX2 mutations are also linked to diencephalic-mesencephalic junction dysplasia (DMJD) syndrome, characterized by developmental delay, hypotonia, and distinctive brain malformations. A novel GSX2 variant, p.Trp249Cys, has been associated with DMJD, suggesting a genotype-phenotype correlation (ÜrelDemir2024Many). In Angelman Syndrome, GSX2 is downregulated due to hyper-methylation, which may contribute to the neurological symptoms observed in this condition (Panov2022An). These findings underscore the critical role of GSX2 in brain development and its potential impact on various neurological disorders.

## Interactions
GSX2, a homeodomain transcription factor, participates in various interactions with proteins and nucleic acids that influence gene regulation. In the mouse lateral ganglionic eminence (LGE), GSX2 interacts with the Ascl1 protein, a basic helix-loop-helix (bHLH) transcription factor. This interaction occurs at the bHLH domain of Ascl1, specifically the second helix, which is involved in protein dimerization. GSX2 inhibits Ascl1-mediated gene expression by disrupting Ascl1 homodimer and Ascl1:Tcf3 heterodimer formation on E-box sequences, thereby competing with Ascl1 and E-proteins for dimer formation and inhibiting Ascl1's ability to bind DNA targets (Roychoudhury2019Physical).

GSX2 also binds to DNA as a monomer or as a cooperative dimer, with its binding properties affecting transcriptional regulation. It preferentially binds to dimer sites (D sites) at low concentrations, stimulating gene expression, while at higher concentrations, it binds to monomer sites (M sites), leading to transcriptional repression. The balance between D and M site binding is crucial for determining regulatory outcomes (Salomone2020Conserved). These interactions highlight GSX2's role in modulating gene expression through both protein-protein and protein-DNA interactions.


## References


1. (Roychoudhury2019Physical) Physical interactions between Gsx2 and Ascl1 regulate the balance between progenitor expansion and neurogenesis in the mouse lateral ganglionic eminence. This article has 0 citations.

[2. (De2019Agenesis) Roberta De Mori, Mariasavina Severino, Maria Margherita Mancardi, Danila Anello, Silvia Tardivo, Tommaso Biagini, Valeria Capra, Antonella Casella, Cristina Cereda, Brett R Copeland, Stella Gagliardi, Alessandra Gamucci, Monia Ginevrino, Barbara Illi, Elisa Lorefice, Damir Musaev, Valentina Stanley, Alessia Micalizzi, Joseph G Gleeson, Tommaso Mazza, Andrea Rossi, and Enza Maria Valente. Agenesis of the putamen and globus pallidus caused by recessive mutations in the homeobox gene gsx2. Brain, 142(10):2965–2978, August 2019. URL: http://dx.doi.org/10.1093/brain/awz247, doi:10.1093/brain/awz247. This article has 13 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awz247)

[3. (Waclaw2009Distinct) Ronald R. Waclaw, Bei Wang, Zhenglei Pei, Lisa A. Ehrman, and Kenneth Campbell. Distinct temporal requirements for the homeobox gene gsx2 in specifying striatal and olfactory bulb neuronal fates. Neuron, 63(4):451–465, August 2009. URL: http://dx.doi.org/10.1016/j.neuron.2009.07.015, doi:10.1016/j.neuron.2009.07.015. This article has 113 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuron.2009.07.015)

[4. (Panov2022An) Julia Panov and Hanoch Kaphzan. An association study of dna methylation and gene expression in angelman syndrome: a bioinformatics approach. International Journal of Molecular Sciences, 23(16):9139, August 2022. URL: http://dx.doi.org/10.3390/ijms23169139, doi:10.3390/ijms23169139. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23169139)

[5. (ÜrelDemir2024Many) Gizem Ürel-Demir, Burak Başer, Rahşan Göçmen, Pelin Özlem Şimşek-Kiper, Gülen Eda Utine, and Göknur Haliloğlu. Many faces of diencephalic-mesencephalic junction dysplasia syndrome with &lt;i&gt;gsx2&lt;/i&gt; and &lt;i&gt;pcdh12&lt;/i&gt; variants. Molecular Syndromology, 15(4):275–283, 2024. URL: http://dx.doi.org/10.1159/000537831, doi:10.1159/000537831. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1159/000537831)

[6. (Pei2011Homeobox) Zhenglei Pei, Bei Wang, Gang Chen, Motoshi Nagao, Masato Nakafuku, and Kenneth Campbell. Homeobox genes gsx1 and gsx2 differentially regulate telencephalic progenitor maturation. Proceedings of the National Academy of Sciences, 108(4):1675–1680, January 2011. URL: http://dx.doi.org/10.1073/pnas.1008824108, doi:10.1073/pnas.1008824108. This article has 72 citations.](https://doi.org/10.1073/pnas.1008824108)

[7. (Salomone2020Conserved) Joseph Salomone, Shenyue Qin, Temesgen D. Fufa, Brittany Cain, Edward Farrow, Bin Guan, Robert B. Hufnagel, Masato Nakafuku, Hee-Woong Lim, Kenneth Campbell, and Brian Gebelein. Conserved gsx2/ind homeodomain monomer versus homodimer dna binding defines regulatory outcomes in flies and mice. Genes &amp; Development, 35(1–2):157–174, December 2020. URL: http://dx.doi.org/10.1101/gad.343053.120, doi:10.1101/gad.343053.120. This article has 19 citations.](https://doi.org/10.1101/gad.343053.120)